SFRP1 Promoter Methylation and Renal Carcinoma Risk: A Systematic Review and Meta-Analysis.

CONCLUSION: Our results indicate that the methylation level of the SFRP1 promoter region is increased in patients with RCC compared to normal controls and might be involved in the occurrence and development of RCC. Additional well-designed studies are needed to further verify our conclusions.
PMID: 29731501 [PubMed - in process]

Source: Journal of Nippon Medical School - May 8, 2018 Category: Universities & Medical Training Authors: Mo S, Su Z, Heng B, Chen W, Shi L, Du X, Lai C Tags: J Nippon Med Sch Source Type: research